Seres Therapeutics
MCRB
#8981
Rank
C$0.13 B
Marketcap
$0.78
Share price
-3.90%
Change (1 day)
-21.59%
Change (1 year)

Earnings for Seres Therapeutics (MCRB)

Earnings in 2024 (TTM): -C$0.18 Billion

According to Seres Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -C$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seres Therapeutics from 2014 to 2024

Annual earnings

Year Earnings Change
2024 -C$0.19 Billion34.63%
2023 -C$0.14 Billion-59.97%
2022 -C$0.35 Billion289.57%
2021 -C$88.71 Million-27.3%
2020 -C$0.13 Billion23%
2019 -C$99.22 Million-30.11%
2018 -C$0.15 Billion9.73%
2017 -C$0.13 Billion-0.74%
2016 -C$0.14 Billion70.96%
2015 -C$76.25 Million257.11%
2014 -C$21.35 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.35 Billion 84.67%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.37 Billion 94.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.61 Billion 223.94%๐Ÿ‡บ๐Ÿ‡ธ USA